bbs 20102011 slide metabolisme
TRANSCRIPT
-
8/3/2019 Bbs 20102011 Slide Metabolisme
1/19
12/30/2012/30/20
METABOLISMEMETABOLISME
DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC
UNIVERSITAS SUMATERA UTARA
dr. Yunita Sari Pane
Pharmacokinetic
absorption
distribution
BIOTRANSFORMATIONelimination
-
8/3/2019 Bbs 20102011 Slide Metabolisme
2/19
12/30/2012/30/20
Oral
Administration
Intestines
Liver
Intravenous
Administration
Metabolism
GI: BiliaryGI: Biliary--Fecal RouteFecal Route
liverliver
bilebile
gall bladdergall bladder
GI trackGI track
bloodblood
Enterohepatic cycleEnterohepatic cycle
-
8/3/2019 Bbs 20102011 Slide Metabolisme
3/19
12/30/2012/30/20
GI: BiliaryGI: Biliary--Fecal RouteFecal Route
lipid soluble drugs have prolongedlipid soluble drugs have prolongedeffectseffects
Oral DrugsOral Drugs
enter stomachenter stomach: highly acidic: highly acidic
environmentenvironment
absorbed by GI tract into portalabsorbed by GI tract into portalcirculation of the livercirculation of the liver
firstfirst--pass effectpass effect
-
8/3/2019 Bbs 20102011 Slide Metabolisme
4/19
12/30/2012/30/20
First Pass EffectFirst Pass Effect
pass throughpass throughliver beforeliver beforereachingreachingcirculationcirculation
undergoundergo
metabolismmetabolismby liverby liver
BiotransformationBiotransformation
chemical alteration of drugchemical alteration of drug
-
8/3/2019 Bbs 20102011 Slide Metabolisme
5/19
12/30/2012/30/20
BiotransformationBiotransformation
changechange
sizesize
lipid solubilitylipid solubility
charge or polaritycharge or polarity
Sites of biotransformationSites of biotransformation
liver: greatest activityliver: greatest activity
othersothers
intestines, kidneys, brain, &intestines, kidneys, brain, &plasmaplasma
-
8/3/2019 Bbs 20102011 Slide Metabolisme
6/19
12/30/2012/30/20
Factors AffectingFactors Affecting
BiotransformationBiotransformation
AgeAge
very youngvery young
less developed enzyme systemless developed enzyme system
less developed blood brainless developed blood brainbarrierbarrier
very oldvery old decreased GI absorptiondecreased GI absorption
decreased renal clearancedecreased renal clearance
-
8/3/2019 Bbs 20102011 Slide Metabolisme
7/19
12/30/2012/30/20
DiseaseDisease
altered liver enzymesaltered liver enzymes
liver diseaseliver disease
most decrease enzymesmost decrease enzymes
some may increasesome may increase
DiseaseDisease
other diseases that decreasedother diseases that decreasedliver enzymesliver enzymes
hypothyroidhypothyroid
hypoxemiahypoxemia
malnutritionmalnutrition
-
8/3/2019 Bbs 20102011 Slide Metabolisme
8/19
12/30/2012/30/20
OtherOther
genetic alterations or defects ingenetic alterations or defects inenzymesenzymes
metabolize drug more slowly ormetabolize drug more slowly ormore rapidlymore rapidly
BiotransformationBiotransformation
-
8/3/2019 Bbs 20102011 Slide Metabolisme
9/19
12/30/2012/30/20
Decreased Activity of Liver EnzymesDecreased Activity of Liver Enzymes
decreased rate of biotransformationdecreased rate of biotransformation
can result in toxic effects
MetabolismMetabolism
(Biotransformation)(Biotransformation)
Two effectsTwo effects
Transformation to less activeTransformation to less activemetabolitemetabolite
Enhancement of solubilityEnhancement of solubility
Liver = primary siteLiver = primary site Liver diseaseLiver disease
Slows metabolismSlows metabolism
Prolongs effectsProlongs effects
-
8/3/2019 Bbs 20102011 Slide Metabolisme
10/19
12/30/2012/30/20
Hepatic FirstHepatic First--PassPass
MetabolismMetabolism
Affects orally administered drugsAffects orally administered drugs
Metabolism of drug by liverMetabolism of drug by liverbefore drug reaches systemicbefore drug reaches systemiccirculationcirculation
Drug absorbed into portalDrug absorbed into portalcirculation, must pass throughcirculation, must pass throughliver to reach systemic circulationliver to reach systemic circulation
May reduce availability of drugMay reduce availability of drug
EliminationElimination
Elimination
Drug Metabolism
(Biotransformation)
Excretion
-
8/3/2019 Bbs 20102011 Slide Metabolisme
11/19
12/30/2012/30/20
Drug MetabolismDrug Metabolism
The chemical modification of drugsThe chemical modification of drugswith the overall goal of getting ridwith the overall goal of getting ridof the drugof the drug
Enzymes are typically involved inEnzymes are typically involved inmetabolismmetabolism
DrugMetabolism More polar
(water soluble)
Drug
Excretion
ABSORPTION METABOLISM ELIMINATIONABSORPTION METABOLISM ELIMINATION
Phase I Phase IIPhase I Phase II
DrugDrug ConjugateConjugate
Drug metabolite with ConjugateDrug metabolite with Conjugatemodified activitymodified activity
DrugDrug
Inactive drug ConjugateInactive drug Conjugatemetabolitemetabolite
DrugDrug
LipophilicLipophilic HydrophilicHydrophilic
-
8/3/2019 Bbs 20102011 Slide Metabolisme
12/19
12/30/2012/30/20
METABOLISM REACTIONMETABOLISM REACTION
I. PHASEI. PHASE -- II
-- Oxidation : Morphin,Oxidation : Morphin,
acetaminophenacetaminophen
-- Reduction : Chloramphenicol,Reduction : Chloramphenicol,
ClonazepamClonazepam
-- Hydrolisis : Aspirin, LidocainHydrolisis : Aspirin, Lidocain
METABOLISM REACTIONMETABOLISM REACTION
II. PHASEII. PHASE-- IIII
-- Conjugation : MorphinConjugation : Morphin
(process glucuroridation),(process glucuroridation),
INH (process acetilation),INH (process acetilation),
etc.etc.
-
8/3/2019 Bbs 20102011 Slide Metabolisme
13/19
12/30/2012/30/20
Sites of Drug MetabolismSites of Drug Metabolism
Metabolism occurs in manyMetabolism occurs in manytissuestissues
E.g. brain, kidney, lungE.g. brain, kidney, lung
But mostly in the liver because But mostly in the liver because
all of the blood in the bodyall of the blood in the body
passes through the liver.passes through the liver.
Consequences Of MetabolismConsequences Of Metabolism
Drug metabolism != DrugDrug metabolism != Druginactivationinactivation
The metabolite may haveThe metabolite may have
EqualEqual activityactivity to the drugto the drug
NoNo oror reducedreduced activityactivity IncreasedIncreased activity (Prodrugs)activity (Prodrugs)
ToxicToxic propertiesproperties
-
8/3/2019 Bbs 20102011 Slide Metabolisme
14/19
12/30/2012/30/20
METABOLISM KINETICMETABOLISM KINETIC
1.First order kinetic1.First order kinetic
if drugs lower dosesif drugs lower doses
metabolism rapidly.metabolism rapidly.
2.Zerro order kinetic2.Zerro order kinetic
if drugs higher dosesif drugs higher doses
metabolism slowly.metabolism slowly.
The Most Important EnzymesThe Most Important Enzymes
Microsomal cytochrome P450Microsomal cytochrome P450monooxygenase family of enzymes,monooxygenase family of enzymes,which oxidize drugswhich oxidize drugs
Act onAct on structurally unrelatedstructurally unrelated drugsdrugs
Metabolize theMetabolize the widestwidest range ofrange ofdrugs.drugs.
-
8/3/2019 Bbs 20102011 Slide Metabolisme
15/19
12/30/2012/30/20
Alteration in first pass metabolismAlteration in first pass metabolism
(note: high clearance(note: high clearancedrug have > 30%drug have > 30%extraction from hepaticextraction from hepaticblood (F < 0.7))blood (F < 0.7))
a drug that inhibitsa drug that inhibitshepatic metabolism willhepatic metabolism willincrease bioavailability ofincrease bioavailability ofhigh clearance drughigh clearance drug(provided it is(provided it is
metabolised by themetabolised by theenzyme(s) inhibited) andenzyme(s) inhibited) andvicevice--versaversa
Examples:Examples:
cimetidine inhibits CYP450s,cimetidine inhibits CYP450s,therefore doubles oraltherefore doubles oralpropranolol bioavailabilitypropranolol bioavailability
phenytoin induces enzymes,phenytoin induces enzymes,therefore decreases felodipinetherefore decreases felodipinebioavailabilitybioavailability
acute alcohol intake inhibits aacute alcohol intake inhibits aCYP, therefore amitriptilineCYP, therefore amitriptilinebioavailability is higherbioavailability is higher
-
8/3/2019 Bbs 20102011 Slide Metabolisme
16/19
12/30/2012/30/20
Enzyme InhibitionEnzyme Inhibition
(drugs that reduce hepatic blood flow(drugs that reduce hepatic blood flowalso inhibit metabolism of highalso inhibit metabolism of highclearance drugs)clearance drugs)
if this metabolic route is a majorif this metabolic route is a majorpathway of elimination, drug kineticspathway of elimination, drug kineticswill change (increase Css and T(1/2))will change (increase Css and T(1/2))and therefore drug response willand therefore drug response willchangechange
enzyme inhibition is immediate, and onenzyme inhibition is immediate, and oncessation of inhibitor, reversion tocessation of inhibitor, reversion tonormal is immediatenormal is immediate
examples:examples:
metronidazole decreasesmetronidazole decreasesclearance of warfarin by 40%clearance of warfarin by 40%
cimetidine decreases clearancecimetidine decreases clearanceof phenytoin by 35%of phenytoin by 35%
propranolo decreases clearancepropranolo decreases clearanceof lignocaine by 50% (byof lignocaine by 50% (byreducing hepatic blood flow)reducing hepatic blood flow)
omeprazole decreases clearanceomeprazole decreases clearanceof warfarinof warfarin
-
8/3/2019 Bbs 20102011 Slide Metabolisme
17/19
12/30/2012/30/20
examples with regards to enzymes otherexamples with regards to enzymes other
than cytochrome P450sthan cytochrome P450s
example 1:example 1:allopurinolallopurinol
is a xanthine oxidase inhibitoris a xanthine oxidase inhibitor(used as an anti(used as an anti--gout agent)gout agent)
also inhibits metabolism ofalso inhibits metabolism ofcytotoxic agent 6cytotoxic agent 6--mercaptopurine (6mercaptopurine (6--MP)MP)
therefore concurrent use oftherefore concurrent use of
allopurinol and 6allopurinol and 6--MP leads toMP leads toelevated plasma levels of 6elevated plasma levels of 6--MPMPand toxicityand toxicity
example 2:example 2:disulfiramdisulfiram
inhibits aldehydeinhibits aldehydedehydrogenasedehydrogenase
therefore is used to givetherefore is used to givealcoholics a nasty "aldehydealcoholics a nasty "aldehyde
reaction" when they takereaction" when they takealcoholalcohol
-
8/3/2019 Bbs 20102011 Slide Metabolisme
18/19
12/30/2012/30/20
Alteration of liver blood flow:Alteration of liver blood flow:
for high first pass clearancefor high first pass clearancedrugs only, a fall in liver blooddrugs only, a fall in liver bloodflow will cause a clear reductionflow will cause a clear reductionin systemic clearancein systemic clearance
example:example:lignocaine toxicity canlignocaine toxicity canoccur when patients are given aoccur when patients are given a
betabeta--blocker which reducesblocker which reducesliver blood flowliver blood flow
ImportanceImportance
Toxic drugs may accumulateToxic drugs may accumulate
Useful drugs may have noUseful drugs may have nobenefit because doses are toobenefit because doses are toosmall to establish therapysmall to establish therapy
A drug can be rapidlyA drug can be rapidlymetabolized.metabolized.
-
8/3/2019 Bbs 20102011 Slide Metabolisme
19/19
12/30/2012/30/20